Ovarian Cancer Market Research Report 2022, Global Industry Trends, Size, Share, Value, Covied 19 Impact And Forecast Till 2027 | IMARC Group
𝐆𝐥𝐨𝐛𝐚𝐥 𝐎𝐯𝐚𝐫𝐢𝐚𝐧 𝐂𝐚𝐧𝐜𝐞𝐫 𝐌𝐚𝐫𝐤𝐞𝐭 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰 (𝟐𝟎𝟐𝟐-𝟐𝟎𝟐𝟕)
• Historical Market Size (2021):US$ 1.68 Billion
• Forecast CAGR (2022-2027):11.40%
𝐈𝐦𝐩𝐚𝐜𝐭 𝐨𝐟 𝐂𝐎𝐕𝐈𝐃-𝟏𝟗:
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐅𝐨𝐫 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 :
𝐖𝐡𝐚𝐭 𝐢𝐬 𝐚 𝐎𝐯𝐚𝐫𝐢𝐚𝐧 𝐂𝐚𝐧𝐜𝐞𝐫 𝐌𝐚𝐫𝐤𝐞𝐭 ?
Ovarian cancer is caused by the abnormal growth of cells in the ovaries that begin to multiply and grow uncontrollably from the outer tissue lining or fallopian tubes due to mutagenic changes in the deoxyribonucleic acid (DNA).
Some commonly known ovarian cancers are epithelial ovarian carcinomas, germ cell tumors, stromal cell tumors, and ovarian sarcoma. They are treated with chemotherapy, surgery, immunotherapy, radiation, and targeted therapies that help kill cancer cells and relieve signs and symptoms.
These therapeutics are performed by medical practitioners after determining multiple factors, such as the spread of the tumor, the individual's general health, and the size and type of ovarian cancer. As a result, ovarian cancer treatment is widely adopted across hospitals and specialty centers.
𝐖𝐡𝐚𝐭 𝐚𝐫𝐞 𝐭𝐡𝐞 𝐦𝐚𝐣𝐨𝐫 𝐦𝐚𝐫𝐤𝐞𝐭 𝐝𝐫𝐢𝐯𝐞𝐫𝐬 𝐢𝐧 𝐭𝐡𝐞 𝐎𝐯𝐚𝐫𝐢𝐚𝐧 𝐂𝐚𝐧𝐜𝐞𝐫 𝐌𝐚𝐫𝐤𝐞𝐭 ?
The market is primarily driven by the increasing prevalence of ovarian cancer. This can be attributed to the family history of ovarian cancer, inhabitation of gene mutation (BRCA1 or BRCA2), lynch syndrome amongst the female geriatric population, obesity, and endometriosis.
In addition, the widespread adoption of combination therapies in the healthcare industry to prevent drug resistance and increase treatment efficacy is contributing to market growth.
Moreover, various initiatives undertaken by non-governmental organizations (NGOs) to sensitize consumers concerning the symptoms, treatments, and benefits of early ovarian cancer diagnosis represent another major growth-inducing factor.
Besides this, the market is further propelled by the extensive investment in cancer research worldwide.
Moreover, with the ongoing patent expiration of branded medications, pharmaceutical companies are introducing novel recombinant drugs.
This, coupled with the extensive research and development (R&D) activities to produce efficient therapeutic interventions and strategic collaborations amongst key players, is creating a positive market outlook across the globe.
𝐀𝐬𝐤 𝐀𝐧𝐚𝐥𝐲𝐬𝐭 𝐟𝐨𝐫 𝐂𝐮𝐬𝐭𝐨𝐦𝐢𝐳𝐚𝐭𝐢𝐨𝐧 𝐚𝐧𝐝 𝐁𝐫𝐨𝐰𝐬𝐞 𝐟𝐮𝐥𝐥 𝐫𝐞𝐩𝐨𝐫𝐭 𝐰𝐢𝐭𝐡 𝐓𝐎𝐂 & 𝐋𝐢𝐬𝐭 𝐨𝐟 𝐅𝐢𝐠𝐮𝐫𝐞:
The report has been segmented the market into following categories:
𝐁𝐫𝐞𝐚𝐤𝐮𝐩 𝐛𝐲 𝐏𝐫𝐨𝐝𝐮𝐜𝐭 𝐓𝐲𝐩𝐞:
o Epithelial Ovarian Cancer
o Germ Cell Ovarian Cancer
o Stromal Cell Ovarian Cancer
𝐁𝐫𝐞𝐚𝐤𝐮𝐩 𝐛𝐲 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐓𝐲𝐩𝐞:
o Targeted Therapy
𝐁𝐫𝐞𝐚𝐤𝐮𝐩 𝐛𝐲 𝐄𝐧𝐝 𝐔𝐬𝐞𝐫:
o Specialty Centre
• North America (United States, Canada)
• Europe (Germany, France, United Kingdom,
Italy, Spain, Others)
• Asia Pacific (China, Japan, India, Australia,
Indonesia, Korea, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa (United Arab Emirates,
Saudi Arabia, Qatar, Iraq, Other)
𝐋𝐢𝐬𝐭 𝐨𝐟 𝐌𝐚𝐣𝐨𝐫 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬:
• AbbVie Inc.
• Amneal Pharmaceuticals Inc.
• AstraZeneca plc, Eli Lilly and Company
• F. Hoffmann-La Roche AG, GSK plc
• Hikma Pharmaceuticals PLC
• Lupin Limited, Pfizer Inc.
• and Teva Pharmaceutical Industries Ltd.
𝐊𝐞𝐲 𝐡𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬 𝐨𝐟 𝐭𝐡𝐞 𝐫𝐞𝐩𝐨𝐫𝐭:
• Market Performance (2016-2021)
• Market Outlook (2022- 2027)
• Porter's Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
𝐁𝐫𝐨𝐰𝐬𝐞 𝐎𝐭𝐡𝐞𝐫 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭-
hair conditioner market Report 2022-2027-
Military Transport Aircraft Market Size 2022-2027
Hydrogel Dressing Market Size 2022-2027-
Nucleotides Market Forecast 2022-2027-
Artificial Vital Organs and Medical Bionics Market Size 2022-2027
Behavioral Mental Health Care Software Market Share 2022-2027-
IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA - Wyoming
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Ovarian Cancer Market Research Report 2022, Global Industry Trends, Size, Share, Value, Covied 19 Impact And Forecast Till 2027 | IMARC Group here
News-ID: 2835028 • Views: 313
More Releases from IMARC Group
Aerospace Fasteners Market to Touch US$ 8.95 Billion by 2027, at a CAGR of 6.1%
According to the latest report by IMARC Group "Aerospace Fasteners Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" The global aerospace fasteners market size reached US$ 6.19 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 8.95 Billion by 2027, exhibiting at a CAGR of 6.1% during 2022-2027. Aerospace fasteners include nuts and bolts, rivets, and screws, which are made of aluminum, titanium, and
Metabolomics Market Size to Reach US$ 4.2 Billion, Globally, by 2027 at 12% CAGR
According to the latest report by IMARC Group, titled, "Metabolomics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" The global metabolomics market reached a value of US$ 2.1 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 4.2 Billion by 2027, exhibiting a CAGR of 12% during 2022-2027. Metabolomics is the study and analysis of small molecules present in cells, biofluids, tissues, and organisms.
Human Growth Hormone Market Size, Key Players, Latest Insights, Trends, Opportun …
According to IMARC Group's latest report, titled "𝗛𝘂𝗺𝗮𝗻 𝗚𝗿𝗼𝘄𝘁𝗵 𝗛𝗼𝗿𝗺𝗼𝗻𝗲 𝗠𝗮𝗿𝗸𝗲𝘁: 𝗚𝗹𝗼𝗯𝗮𝗹 𝗜𝗻𝗱𝘂𝘀𝘁𝗿𝘆 𝗧𝗿𝗲𝗻𝗱𝘀, 𝗦𝗵𝗮𝗿𝗲, 𝗦𝗶𝘇𝗲, 𝗚𝗿𝗼𝘄𝘁𝗵, 𝗢𝗽𝗽𝗼𝗿𝘁𝘂𝗻𝗶𝘁𝘆 𝗮𝗻𝗱 𝗙𝗼𝗿𝗲𝗰𝗮𝘀𝘁 𝟮𝟬𝟮𝟮-𝟮𝟬𝟮𝟳", The market to reach US$ 7.9 Billion by 2027, exhibiting a CAGR of 8.47% during 2022-2027. Human growth hormone, also known as HGH, refers to a peptide hormone that is produced by the pituitary gland to stimulate growth in children and adults. It generally regulates the regeneration, repair, reproduction, and
Vanilla and Vanillin Market Size, Share, Industry Trends, Insights, Opportunity …
According to the latest report by IMARC Group, titled "𝗩𝗮𝗻𝗶𝗹𝗹𝗮 𝗮𝗻𝗱 𝗩𝗮𝗻𝗶𝗹𝗹𝗶𝗻 𝗠𝗮𝗿𝗸𝗲𝘁: 𝗚𝗹𝗼𝗯𝗮𝗹 𝗜𝗻𝗱𝘂𝘀𝘁𝗿𝘆 𝗧𝗿𝗲𝗻𝗱𝘀, 𝗦𝗵𝗮𝗿𝗲, 𝗦𝗶𝘇𝗲, 𝗚𝗿𝗼𝘄𝘁𝗵, 𝗢𝗽𝗽𝗼𝗿𝘁𝘂𝗻𝗶𝘁𝘆 𝗮𝗻𝗱 𝗙𝗼𝗿𝗲𝗰𝗮𝘀𝘁 𝟮𝟬𝟮𝟮-𝟮𝟬𝟮𝟳", the global vanilla and vanillin market size reached US$ 5,277.70 Million in 2021. Looking forward, IMARC Group expects the market is anticipated to reach a value of US$ 6,629.10 Million by 2027, exhibiting a CAGR of 4.10% during 2022-2027. Vanilla is a dried, cured flavoring component derived from
More Releases for Ovarian
Polycystic Ovarian Syndrome Treatment Market Report
The findings reviewed by GME stated that the Global Polycystic Ovarian Syndrome Treatment Market will expand with a CAGR value of 5.2 percent from 2021 to 2026. The rising incidence of PCOS increased understanding among a group of patients, and the growing acceptance of standard treatment boosts the PCOS treatment industry growth over the projected timeframe. Furthermore, the research and development of PCOS are predicted to aid in market growth. Browse
How deadly is Ovarian Cancer?
Ovarian Drugs and Treatment Market describes its growth, size, share, Forecast and trends to 2025 Ovarian cancer is a cancer that forms in or on an ovary. It results in abnormal cells that have the ability to invade or spread to other parts of the body. The global Ovarian Cancer Treatment Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025,
Polycystic Ovarian Syndrome - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Polycystic Ovarian Syndrome - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Polycystic Ovarian Syndrome - Pipeline Review, H2 2017, provides an overview of the Polycystic Ovarian Syndrome (Women's Health) pipeline landscape. Polycystic ovary syndrome (PCOS) is a common hormonal disorder among women of reproductive age. Symptoms
Ovarian Cancer Drugs Market Report : 2017
Reports And Markets Publish a New Market Research Report On –"Ovarian Cancer Drugs Market Report : 2017" Access Full Report With Table Of Contents @ https://www.reportsandmarkets.com/reports/united-states-ovarian-cancer-drugs-market-report-2017-1541150 In this report, the United States Ovarian Cancer Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United
Ovarian Cancer - Pipeline Review, H1 2017
Report Hive Market Research Released a New Research Report of 2027 pages on Title " Ovarian Cancer - Pipeline Review, H1 2017 "with detailed Analysis, Forecast and Strategies. Ovarian Cancer - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ovarian Cancer - Pipeline Review, H1 2017, provides an overview of the Ovarian Cancer (Oncology) pipeline landscape. Ovarian cancer is any cancerous growth that may occur in different
Ovarian Cancer - Heat Map and Analysis
ReportsWorldwide has announced the addition of a new report title Ovarian Cancer - Heat Map and Analysis to its growing collection of premium market research reports. Ovarian Cancer (OC) is the fifth most common malignancy diagnosed in women, and the most common gynecological cancer, with an estimated 225,000 new cases diagnosed globally in 2008. Rates are particularly high in developed countries, and especially in Northern Europe. However, substantial improvements in